VOLTAREN EMULGEL 1.16% (Tube) Price

Overview

Welcome to Dwaey, specifically on VOLTAREN EMULGEL 1.16% (Tube) page.
This medicine contains an important and useful components, as it consists of
Diclofenac diethylamine is available in the market in concentration

Name

Phospholipids

Precaution

Before using **Phospholipids**, patients should follow these precautions and consult their healthcare provider for professional guidance: - **Allergy or Sensitivity**: Phospholipids can cause allergic reactions in some individuals, especially if derived from egg or soy sources. If you have known allergies to these products, discuss the potential risks with your doctor before use. - **Liver and Kidney Function**: Those with **impaired liver** or **kidney function** should use phospholipid-based products cautiously, as these organs play a role in metabolizing lipids, and impaired function may alter the drug's efficacy or cause adverse effects. - **Pregnancy and Breastfeeding**: Phospholipids are generally considered safe for use during pregnancy and breastfeeding, but their use should still be discussed with a healthcare provider to ensure safety for both the mother and child. - **Chronic Conditions**: Patients with **diabetes**, **hyperlipidemia**, or **cardiovascular disease** should use phospholipid products with caution. These patients may be more susceptible to lipid imbalances, which could be influenced by phospholipids in the body. - **Topical Use**: When using phospholipids in topical products, it is important to monitor for any irritation or allergic reactions. A patch test is recommended before widespread use.

Indication

Phospholipids have a broad range of medical and therapeutic applications. Their most common indications include: - **Lipid Replacement Therapy**: Phospholipids are used in lipid-based formulations to replenish lipids in patients with **lipid metabolism disorders** or those undergoing **parenteral nutrition** (PN) therapy. - **Lung Surfactant Replacement**: Used in the treatment of **respiratory distress syndrome (RDS)**, particularly in premature infants. The phospholipid **surfactant** helps reduce surface tension in the lungs, improving lung function and oxygen exchange. - **Liver Diseases**: In some forms, phospholipids (particularly phosphatidylcholine) are used to support liver health, especially in patients with **hepatitis** or **fatty liver disease**, helping to repair liver cell membranes. - **Liposome Encapsulation**: Phospholipids are used in creating **liposomes** for the delivery of drugs, including chemotherapy agents and vaccines, improving the stability and targeting of the drugs to specific tissues. - **Topical Treatment**: Phospholipids are used in **cosmetic formulations** to enhance skin hydration, reduce inflammation, and repair damaged skin, such as in **eczema** or **dermatitis** treatments.

Contra indication

Phospholipids should not be used under the following conditions: - **Hypersensitivity**: If a patient is known to be **allergic to phospholipids** or any of their components, such as **egg** or **soy** derivatives, they should avoid using products containing phospholipids. - **Severe Liver Disease**: Patients with **severe hepatic dysfunction** should avoid phospholipid formulations unless under strict medical supervision, as their ability to metabolize lipids may be compromised. - **Severe Renal Impairment**: In cases of severe kidney dysfunction, care should be taken when using phospholipid-based treatments, as the kidneys are involved in lipid metabolism and excretion. - **Pregnancy and Lactation**: Although phospholipids are generally safe, it is crucial to consult a healthcare provider during **pregnancy** and **breastfeeding** to weigh potential risks and benefits. - **Lipid Metabolism Disorders**: Conditions that involve abnormal lipid metabolism (such as **hyperlipidemia** or **lipid storage diseases**) may warrant caution or avoidance of phospholipid treatments to prevent exacerbating the condition.

Side Effect

Although phospholipids are generally well tolerated, patients should monitor for the following potential side effects: - **Common Side Effects**: - **Injection Site Reactions**: For phospholipids used in intravenous formulations (such as surfactant therapy), common reactions may include **pain**, **swelling**, or **redness** at the injection site. - **Gastrointestinal Discomfort**: Oral phospholipids can cause mild **nausea**, **diarrhea**, or **bloating** in some individuals. - **Skin Irritation**: Topical formulations may cause **mild redness** or **itching** in sensitive individuals. - **Severe Side Effects**: - **Severe Allergic Reactions**: In rare cases, especially in individuals with egg or soy allergies, phospholipid-based products may lead to **anaphylaxis**, which requires immediate medical attention. - **Liver Enzyme Elevation**: In rare cases, prolonged use of phospholipids for liver health may result in **elevated liver enzymes**, indicating potential liver stress or damage. - **Pulmonary Adverse Events**: When used in neonatal surfactant therapy, **respiratory distress**, **pulmonary hemorrhage**, or other severe pulmonary events may occur, particularly in very premature infants.

Pregnancy Category ID

0

Mode of Action

Phospholipids exert their therapeutic effects through various mechanisms depending on the form and application: - **Surfactant Action**: In **respiratory distress syndrome (RDS)**, phospholipids (specifically **phosphatidylcholine**) are a key component of lung surfactant, which reduces surface tension in the lungs and helps prevent the collapse of alveoli, making it easier to breathe. - **Membrane Repair and Lipid Balance**: Phospholipids play a critical role in the structure and function of **cell membranes**. They help repair damaged liver cells, promote cell regeneration, and maintain overall lipid balance in the body. - **Drug Delivery Systems**: In liposomal formulations, phospholipids form a **lipid bilayer** that encapsulates drugs, providing **controlled release**, **enhanced stability**, and **targeted delivery** to specific tissues or organs. This is particularly useful in **chemotherapy**, **vaccine delivery**, and **antibiotic treatments**.

Interaction

Phospholipids have minimal systemic drug interactions, but they may interact with other treatments, especially those affecting lipid metabolism: - **Cholesterol-Lowering Agents**: Drugs such as **statins** that reduce cholesterol might interact with phospholipid formulations used for lipid replacement, altering lipid balance in the body. Monitoring is recommended for patients on both treatments. - **Anticoagulants**: Phospholipids, particularly in intravenous or injectable forms, may interact with anticoagulants (like **warfarin**) due to their potential effect on **blood clotting**. Close monitoring of coagulation status is necessary. - **Topical Steroids**: If phospholipids are used in topical formulations with **corticosteroids**, there is a possibility of **enhanced absorption** of the steroid, leading to an increased systemic effect. - **Lipophilic Drugs**: When used in drug delivery systems (such as liposomes), phospholipids can affect the release and absorption of lipophilic drugs. The interaction may alter drug efficacy or lead to side effects depending on the lipophilic drug used.

Pregnancy Category Note

Information not available

Adult Dose

The dosing of phospholipids will depend on the formulation and therapeutic goal. Typical doses include: - **Parenteral Nutrition**: For patients requiring lipid replacement, **lipid emulsions** containing phospholipids may be used. The recommended dose is generally **1-2 g/kg/day**, adjusted according to the patient's clinical condition and lipid requirements. - **Lung Surfactant Therapy**: For premature infants with RDS, the dosing of **exogenous surfactant** (containing phospholipids) is typically around **100-200 mg/kg** body weight, administered **intratracheally** in multiple doses during the first few days after birth. - **Topical Applications**: Phospholipid-containing creams or ointments should be applied to the affected area once or twice daily, based on the severity of the skin condition. The amount of topical formulation will vary depending on the product's concentration and the area to be treated.

Child Dose

- **Neonatal Surfactant**: For neonates with **respiratory distress syndrome (RDS)**, **exogenous surfactant containing phospholipids** is administered via **intratracheal tube**, with dosing based on the infant's body weight, typically in the range of **100-200 mg/kg** of body weight. - **Topical Use**: For children using **topical phospholipid creams** or **ointments**, apply a thin layer once or twice daily. The dose will depend on the formulation and the size of the affected area. As always, **consult a healthcare provider** before starting any treatment, including those involving phospholipids, to ensure proper usage and avoid potential risks.

Renal Dose

Phospholipid-based treatments are generally not significantly affected by renal function, as they are largely metabolized in the liver or utilized at the site of application. However, caution should be taken when administering phospholipids to patients with **severe renal impairment**, especially if the treatment involves **parenteral nutrition** or other systemic formulations, as the body's ability to excrete lipids and metabolites may be compromised. Regular monitoring of kidney function is recommended.

Administration

Information not available